unknown
Stage
About
Epana Bio is a biotechnology company developing precision therapies for autoimmune diseases by targeting the cellular origin of autoimmunity. It uses genomics and AI to design patient-tailored treatments intended to reset the immune system rather than just manage symptoms.
Explore Epana Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.